PEPD is a pivotal regulator of p53 tumor suppressor

被引:0
|
作者
Lu Yang
Yun Li
Arup Bhattacharya
Yuesheng Zhang
机构
[1] Roswell Park Cancer Institute,Department of Pharmacology and Therapeutics
[2] Roswell Park Cancer Institute,Department of Urology
[3] Roswell Park Cancer Institute,Department of Cancer Prevention and Control
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
p53 tumor suppressor responds to various cellular stresses and regulates cell fate. Here, we show that peptidase D (PEPD) binds and suppresses over half of nuclear and cytoplasmic p53 under normal conditions, independent of its enzymatic activity. Eliminating PEPD causes cell death and tumor regression due to p53 activation. PEPD binds to the proline-rich domain in p53, which inhibits phosphorylation of nuclear p53 and MDM2-mediated mitochondrial translocation of nuclear and cytoplasmic p53. However, the PEPD-p53 complex is critical for p53 response to stress, as stress signals doxorubicin and H2O2 each must free p53 from PEPD in order to achieve robust p53 activation, which is mediated by reactive oxygen species. Thus, PEPD stores p53 for the stress response, but this also renders cells dependent on PEPD for survival, as it suppresses p53. This finding provides further understanding of p53 regulation and may have significant implications for the treatment of cancer and other diseases.
引用
收藏
相关论文
共 50 条
  • [1] PEPD is a pivotal regulator of p53 tumor suppressor
    Yang, Lu
    Li, Yun
    Bhattacharya, Arup
    Zhang, Yuesheng
    NATURE COMMUNICATIONS, 2017, 8
  • [2] PEPD is an essential regulator of p53 tumor suppressor
    Yang, Lu
    Li, Yun
    Bhattacharya, Arup
    Zhang, Yuesheng
    CANCER RESEARCH, 2018, 78 (13)
  • [3] disrupting binding of p53 mutants to PEPD unleashes their tumor suppressor activities.
    Yang, Lu
    CANCER RESEARCH, 2021, 81 (13)
  • [4] The p53 tumor suppressor as a regulator of innate immunity genes
    Shatz, Maria
    Menendez, Daniel
    Resnick, Michael
    CANCER RESEARCH, 2009, 69
  • [5] The p53 tumor suppressor: Critical regulator of life & death in cancer
    D. E. Fisher
    Apoptosis, 2001, 6 : 7 - 15
  • [6] The p53 tumor suppressor: Critical regulator of life & death in cancer
    Fisher, DE
    APOPTOSIS, 2001, 6 (1-2) : 7 - 15
  • [7] CARF: An emerging regulator of p53 tumor suppressor and senescence pathway
    Cheung, Caroline T. Y.
    Hasan, Md. Kamrul
    Widodo, Nashi
    Kaul, Sunil C.
    Wadhwa, Renu
    MECHANISMS OF AGEING AND DEVELOPMENT, 2009, 130 (1-2) : 18 - 23
  • [8] MDM2 - master regulator of the p53 tumor suppressor protein
    Momand, J
    Wu, HH
    Dasgupta, G
    GENE, 2000, 242 (1-2) : 15 - 29
  • [9] The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways
    Yu, CL
    Driggers, P
    BarreraHernandez, G
    Nunez, SB
    Segars, JH
    Cheng, SY
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (02) : 617 - 620
  • [10] The p53 tumor suppressor targets a novel regulator of G protein signaling
    Buckbinder, L
    VelascoMiguel, S
    Chen, Y
    Xu, NZ
    Talbott, R
    Gelbert, L
    Gao, JZ
    Seizinger, BR
    Gutkind, JS
    Kley, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) : 7868 - 7872